Zynda ER - Search Results

1

Current Perspectives on "Off-The-Shelf" Allogeneic NK and CAR-NK Cell Therapies.

Heipertz EL, Zynda ER, Stav-Noraas TE, Hungler AD, Boucher SE, Kaur N, Vemuri MC. Heipertz EL, et al. Among authors: zynda er. Front Immunol. 2021 Dec 1;12:732135. doi: 10.3389/fimmu.2021.732135. eCollection 2021. Front Immunol. 2021. PMID: 34925314 Free PMC article. Review.

2

Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments.

Ecker C, Guo L, Voicu S, Gil-de-Gómez L, Medvec A, Cortina L, Pajda J, Andolina M, Torres-Castillo M, Donato JL, Mansour S, Zynda ER, Lin PY, Varela-Rohena A, Blair IA, Riley JL. Ecker C, et al. Among authors: zynda er. Cell Rep. 2018 Apr 17;23(3):741-755. doi: 10.1016/j.celrep.2018.03.084. Cell Rep. 2018. PMID: 29669281 Free PMC article.

3

A role for the thermal environment in defining co-stimulation requirements for CD4(+) T cell activation.

Zynda ER, Grimm MJ, Yuan M, Zhong L, Mace TA, Capitano M, Ostberg JR, Lee KP, Pralle A, Repasky EA. Zynda ER, et al. Cell Cycle. 2015;14(14):2340-54. doi: 10.1080/15384101.2015.1049782. Cell Cycle. 2015. PMID: 26131730 Free PMC article.

4

Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia.

Mace TA, Zhong L, Kilpatrick C, Zynda E, Lee CT, Capitano M, Minderman H, Repasky EA. Mace TA, et al. J Leukoc Biol. 2011 Nov;90(5):951-62. doi: 10.1189/jlb.0511229. Epub 2011 Aug 26. J Leukoc Biol. 2011. PMID: 21873456 Free PMC article.

5

Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia.

Peer AJ, Grimm MJ, Zynda ER, Repasky EA. Peer AJ, et al. Among authors: zynda er. Immunol Res. 2010 Mar;46(1-3):137-54. doi: 10.1007/s12026-009-8115-8. Immunol Res. 2010. PMID: 19756410 Review.

6

Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivo.

Arnouk H, Zynda ER, Wang XY, Hylander BL, Manjili MH, Repasky EA, Subjeck JR, Latif Kazim A. Arnouk H, et al. Among authors: zynda er. Int J Hyperthermia. 2010;26(4):366-75. doi: 10.3109/02656730903485910. Int J Hyperthermia. 2010. PMID: 20210603 Free PMC article.

7

The role of PAK1 in the sensitivity of kidney epithelial cells to ischemia-like conditions.

Zynda ER, Maloy MH, Kandel ES. Zynda ER, et al. Cell Cycle. 2019 Mar;18(5):596-604. doi: 10.1080/15384101.2019.1578149. Epub 2019 Feb 11. Cell Cycle. 2019. PMID: 30724698 Free PMC article.

8

Protein kinase A type II-α regulatory subunit regulates the response of prostate cancer cells to taxane treatment.

Zynda ER, Matveev V, Makhanov M, Chenchik A, Kandel ES. Zynda ER, et al. Cell Cycle. 2014;13(20):3292-301. doi: 10.4161/15384101.2014.949501. Cell Cycle. 2014. PMID: 25485509 Free PMC article.

9

ETV1 positively regulates transcription of tumor suppressor ARF.

Zynda E, Jackson MW, Bhattacharya P, Kandel ES. Zynda E, et al. Cancer Biol Ther. 2013 Dec;14(12):1167-73. doi: 10.4161/cbt.26883. Epub 2013 Oct 23. Cancer Biol Ther. 2013. PMID: 24157551 Free PMC article.

10

An RNA interference screen identifies new avenues for nephroprotection.

Zynda ER, Schott B, Babagana M, Gruener S, Wernher E, Nguyen GD, Ebeling M, Kandel ES. Zynda ER, et al. Cell Death Differ. 2016 Apr;23(4):608-15. doi: 10.1038/cdd.2015.128. Epub 2015 Nov 13. Cell Death Differ. 2016. PMID: 26564400 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page